Registry for patients with endocrine tumors undergoing surgery
Registre Tumeurs Endocrine - Eurocrine
This study is collecting information from patients with endocrine tumors who are having surgery to help improve treatment and care for these rare conditions across Europe.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Sex | All |
| Sponsor | Central Hospital, Nancy, France Academic / other |
| Locations | 1 site (Vandœuvre-lès-Nancy) |
| Trial ID | NCT03410394 on ClinicalTrials.gov |
What this trial studies
This registry collects data on patients with endocrine tumors, including those affecting the thyroid, parathyroid, adrenal glands, endocrine pancreas, and digestive tube, who are undergoing surgical procedures. It is part of the Eurocrine Project, which aims to create a pan-European database to improve the understanding and treatment of these rare tumors. By recording and analyzing data at a European level, the project seeks to enhance clinical standards and reduce variations in practice across different clinics and countries. The ultimate goal is to decrease morbidity and mortality associated with these rare endocrine tumors through improved knowledge and practices.
Who should consider this trial
Good fit: Ideal candidates for this registry are patients undergoing surgical procedures for endocrine tumors at the University Nancy Brabois Hospital.
Not a fit: Patients who are unable to provide informed consent or refuse to participate will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could lead to improved diagnosis and treatment protocols for patients with rare endocrine tumors.
How similar studies have performed: Other studies have shown success in utilizing registries to improve outcomes for rare conditions, making this approach promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients who undergo surgical procedures for endocrine tumors at the University Nancy Brabois Hospital Exclusion Criteria: * unable to receive clear information * refusal to sign the consent form
Where this trial is running
Vandœuvre-lès-Nancy
- CHU Nancy — Vandœuvre-lès-Nancy, France (Recruiting)
Study contacts
- Principal investigator: laurent Brunaud — University of Lorraine
- Study coordinator: laurent Brunaud, MD, PhD
- Email: l.brunaud@chru-nancy.fr
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.